Monte Rosa Therapeutics Inc
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.50 | 0.52 | -0.63 | -0.39 | -0.26 | 2.10 | -0.55 | -0.56 | 1.63 | -0.66 | -0.44 | -0.96 | -0.72 | |
| 0.04 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.02 | 0.03 | 0.03 | 0.03 | 0.02 | 0.05 | 0.12 | |
| 0.09 | 0.07 | 0.08 | 0.06 | 0.05 | 0.07 | 0.06 | 0.08 | 0.07 | 0.07 | 0.07 | 0.14 | 0.31 | |
| 0.09 | 1.01 | -0.21 | -0.04 | -0.03 | 1.78 | -1.19 | -0.47 | 1.97 | -0.05 | 0.00 | -0.09 | 1.30 | |
| 0.03 | 0.03 | 0.02 | 0.03 | 0.00 | 0.00 | 0.02 | 0.03 | 0.01 | 0.01 | 0.02 | 0.08 | 0.12 | |
| 0.72 | 0.25 | 0.16 | -0.86 | 0.46 | -0.50 | -1.21 | 0.41 | 0.62 | -0.99 | -3.10 | -3.40 | -6.78 | |
| – | – | – | – | – | 0.00 | – | – | – | -0.01 | – | – | – | |
| 0.02 | 0.44 | 0.00 | 1.38 | 0.00 | 0.01 | 0.00 | 0.01 | 0.01 | 0.45 | 3.89 | 3.89 | 8.09 | |
| 0.24 | 1.21 | -0.47 | 0.13 | 0.20 | 1.61 | -1.76 | -0.15 | 2.25 | -1.20 | 0.36 | -0.47 | 0.59 | |
| -0.53 | 0.49 | -0.66 | -0.42 | -0.26 | 2.10 | -0.57 | -0.59 | 1.61 | -0.67 | -0.47 | -1.03 | -0.84 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.